ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
ILLUMINA, INC.
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Jul 31, 2026
$262.66+0.12 (+0.05%)
Close on Oct 19, 2026
- Market cap
- $40.19B
- P/E (TTM)
- 48.8
- Dividend yield
- –
ILLUMINA, INC. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Core Illumina | $1.16B | $1.09B | $1.16B | $1.08B | $1.06B | $1.04B | $1.10B | $1.08B | $1.09B | $1.06B | $1.10B | $1.11B | 100.0% | +9.4% |
| Sequencing | $1.05B | $995.00M | $1.07B | $1.00B | $972.00M | $947.00M | $1.00B | $995.00M | $1.02B | $979.00M | $1.02B | $1.03B | 90.9% | +8.4% |
| Microarray | $105.00M | $96.00M | $93.00M | $83.00M | $87.00M | $94.00M | $100.00M | $85.00M | $96.00M | $97.00M | $98.00M | $90.00M | 9.1% | +20.7% |
| GRAIL | – | – | $0 | $0 | $0 | $0 | $0 | $0 | $29.00M | $27.00M | $31.00M | $21.00M | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Core Illumina | $245.00M | – | – | – | $214.00M | – | – | $741.00M | $442.00M | $116.00M | $33.00M | $262.00M | +14.5% |
| GRAIL | – | – | – | – | – | – | – | $0 | -$2.08B | -$227.00M | -$197.00M | -$1.02B | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total product revenue | $982.00M | $917.00M | $990.00M | $927.00M | $912.00M | $880.00M | $938.00M | $914.00M | $927.00M | $876.00M | $923.00M | $941.00M | 84.7% | +7.7% |
| Consumables | $852.00M | $797.00M | $832.00M | $816.00M | $811.00M | $768.00M | $779.00M | $807.00M | $807.00M | $762.00M | $756.00M | $760.00M | 73.5% | +5.1% |
| Service | $177.00M | $174.00M | $169.00M | $157.00M | $147.00M | $161.00M | $166.00M | $166.00M | $185.00M | $200.00M | $199.00M | $178.00M | 15.3% | +20.4% |
| Instruments | $130.00M | $120.00M | $158.00M | $111.00M | $101.00M | $112.00M | $159.00M | $107.00M | $120.00M | $114.00M | $167.00M | $181.00M | 11.2% | +28.7% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States and Canada | $653.00M | $590.00M | – | – | $569.00M | $555.00M | – | – | – | – | – | – | 56.3% | +14.8% |
| Europe, Middle East, Africa and Latin America | $368.00M | $356.00M | – | – | $355.00M | $332.00M | – | – | – | – | – | – | 31.8% | +3.7% |
| Asia-Pacific | $82.00M | $93.00M | – | – | $72.00M | $82.00M | – | – | – | – | – | – | 7.1% | +13.9% |
| China | $56.00M | $52.00M | $56.00M | $52.00M | $63.00M | $72.00M | $80.00M | $75.00M | $75.00M | $78.00M | $82.00M | $98.00M | 4.8% | -11.1% |
| Europe | – | – | $353.00M | $309.00M | $310.00M | $293.00M | $326.00M | $291.00M | $289.00M | $279.00M | $315.00M | $260.00M | – | – |
| Americas | – | – | $638.00M | $612.00M | $586.00M | $570.00M | $589.00M | $609.00M | $640.00M | $603.00M | $601.00M | $663.00M | – | – |
| Asia-Pacific, Middle East and Africa | – | – | $112.00M | $111.00M | $100.00M | $106.00M | $109.00M | $105.00M | $108.00M | $116.00M | $124.00M | $98.00M | – | – |
From the segment and revenue-disaggregation notes of Illumina's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.